Tetralogy of fallot epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
(New page: {{Tetralogy of fallot}} {{CMG}} '''Associate Editors-In-Chief:''' Keri Shafer, M.D. [mailto:kshafer@bidmc.harvard.edu]; Atif Mohammad, M.D., Priyamvada Singh, [[M...)
 
No edit summary
Line 1: Line 1:
{{Tetralogy of fallot}}
{{Tetralogy of fallot}}


{{CMG}}
{{CMG}}; '''Associate Editors-In-Chief:''' [[Priyamvada Singh| Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org], [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; Atif Mohammad, M.D.; '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@perfuse.org]
 
==Overview==
'''Associate Editors-In-Chief:''' [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; Atif Mohammad, M.D., [[Priyamvada Singh]], [[MBBS]]
 
 
==Epidemiology and etiology==
==Epidemiology and etiology==
Tetralogy of Fallot occurs in approximately 3 to 6 per 10,000 births and represents 5-7% of congenital heart defects.  Its cause is thought to be due to environmental or genetic factors or a combination.  It is associated with chromosome 22 deletions and [[diGeorge syndrome]].  It occurs slightly more often in males than in females.
Tetralogy of Fallot occurs in approximately 3 to 6 per 10,000 births and represents 5-7% of congenital heart defects.  Its cause is thought to be due to environmental or genetic factors or a combination.  It is associated with chromosome 22 deletions and [[diGeorge syndrome]].  It occurs slightly more often in males than in females.

Revision as of 13:33, 14 August 2011

Tetralogy of fallot Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tetalogy of Fallot from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ACC/AHA Guidelines for Evaluation and Follow-up


Tetralogy of fallot epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tetralogy of fallot epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tetralogy of fallot epidemiology and demographics

CDC on Tetralogy of fallot epidemiology and demographics

Tetralogy of fallot epidemiology and demographics in the news

Blogs on Tetralogy of fallot epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Tetralogy of fallot epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2], Keri Shafer, M.D. [3]; Atif Mohammad, M.D.; Assistant Editor-In-Chief: Kristin Feeney, B.S. [4]

Overview

Epidemiology and etiology

Tetralogy of Fallot occurs in approximately 3 to 6 per 10,000 births and represents 5-7% of congenital heart defects. Its cause is thought to be due to environmental or genetic factors or a combination. It is associated with chromosome 22 deletions and diGeorge syndrome. It occurs slightly more often in males than in females.

See also

References

External links

Template:SIB

de:Fallot-Tetralogie it:Tetralogia di Fallot nl:Tetralogie van Fallot nn:Fallots tetrade uk:Тетрада Фалло


Template:WikiDoc Sources